“Pathogenetic mechanisms underlying contrast-induced nephropathy in coronary artery disease and type 2 diabetes patients: innovative approaches and future directions” (2024) CARDIOLOGY OF UZBEKISTAN, 1(1), pp. 3–13. doi:10.70626/cardiouz-2024-1-00001.